ezetimibe has been researched along with Hyperphagia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, D; Hirata, Y; Kim-Kaneyama, JR; Kitagawa, T; Kurobe, H; Lei, XF; Masuzaki, H; Okawa, C; Sata, M; Sato, M; Shimabukuro, M; Soeki, T; Sugasawa, N; Takao, S; Tanaka, Y; Uematsu, E; Yagi, S; Yamada, H; Yanagi, S | 1 |
1 other study(ies) available for ezetimibe and Hyperphagia
| Article | Year |
|---|---|
The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe.
Topics: Adipose Tissue, White; Adiposity; Animals; Anticholesteremic Agents; Cardiomegaly; Cholesterol; Ezetimibe; Gastrointestinal Agents; Gene Expression Regulation, Enzymologic; Heart; Heart Diseases; Hydroxycholesterols; Hyperphagia; Intestinal Absorption; Lipoproteins, LDL; Liver; Male; Myocardium; Oxidation-Reduction; Pericardium; Random Allocation; Sus scrofa | 2016 |